CLASS ACTION REMINDER: Berger Montague Advises Outlook Therapeutics, Inc. (NASDAQ: OTLK) Investors to Inquire About a Securities Fraud Lawsuit by January 2, 2024PRNewsWire • 11/27/23
Outlook Therapeutics® Announces Receipt of Type A Meeting Minutes and Reiterates Regulatory Path Forward for ONS-5010GlobeNewsWire • 11/27/23
SHAREHOLDER ALERT: The Law Offices of Vincent Wong Remind Outlook Investors of a Lead Plaintiff Deadline of January 2, 2024PRNewsWire • 11/27/23
ROSEN, NATIONAL TRIAL COUNSEL, Encourages Outlook Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - OTLKPRNewsWire • 11/26/23
OTLK INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Outlook Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!Business Wire • 11/21/23
Outlook Therapeutics, Inc. Class Action Alert: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a securities class action lawsuit has been filed in the United States District Court for the District of New Jersey against Outlook TherapeuticPRNewsWire • 11/21/23
OUTLOOK SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Outlook To Contact Him Directly To Discuss Their OptionsPRNewsWire • 11/18/23
ROSEN, LEADING INVESTOR COUNSEL, Encourages Outlook Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - OTLKPRNewsWire • 11/18/23
OTLK STOCKHOLDERS: Contact Robbins LLP for Information About Your Rights Against Outlook Therapeutics, Inc.Business Wire • 11/15/23
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Outlook Therapeutics, Inc. with Losses of $100,000 to Contact the FirmAccesswire • 11/15/23
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Outlook Therapeutics, Inc. (OTLK)Business Wire • 11/14/23
Outlook Therapeutics® Adds Global Commercial Expertise with Appointment of Jedd Comiskey as Senior VP - Head of EuropeGlobeNewsWire • 11/14/23
INVESTOR ACTION ALERT: The Schall Law Firm Encourages Investors in Outlook Therapeutics, Inc. with Losses of $500,000 to Contact the FirmAccesswire • 11/14/23
Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Outlook Therapeutics, Inc. (OTLK)Business Wire • 11/13/23
ATTENTION NASDAQ: OTLK INVESTORS: Contact Berger Montague About an Outlook Therapeutics, Inc. Class Action LawsuitPRNewsWire • 11/13/23
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Outlook Therapeutics, Inc. with Losses of $500,000 to Contact the FirmAccesswire • 11/13/23
OTLK INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Outlook Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitBusiness Wire • 11/11/23
ROSEN, AN INVESTOR RIGHTS LAW FIRM, Encourages Outlook Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - OTLKPRNewsWire • 11/11/23
Outlook Therapeutics, Inc. (OTLK) Investor Notice: Robbins LLP Reminds Investors of Class Action Filed Against Outlook Therapeutics, Inc.Business Wire • 11/09/23
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Outlook Therapeutics, Inc. (OTLK) InvestorsBusiness Wire • 11/09/23
INVESTOR ACTION ALERT: The Schall Law Firm Encourages Investors in Outlook Therapeutics, Inc. with Losses of $100,000 to Contact the FirmAccesswire • 11/09/23
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Outlook Therapeutics, Inc. (OTLK) InvestorsBusiness Wire • 11/08/23
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Outlook Therapeutics, Inc. (OTLK) on Behalf of InvestorsBusiness Wire • 11/07/23
